Boxer Capital 13F annual report

Boxer Capital is an investment fund managing more than $1.9 trillion ran by Aaron Davis. There are currently 57 companies in Mr. Davis’s portfolio. The largest investments include SpringWorks Therapeutics and Cytokinetics Inc, together worth $316 billion.

Limited to 30 biggest holdings

$1.9 trillion Assets Under Management (AUM)

As of 8th May 2024, Boxer Capital’s top holding is 3,421,541 shares of SpringWorks Therapeutics currently worth over $168 billion and making up 8.3% of the portfolio value. Relative to the number of outstanding shares of SpringWorks Therapeutics, Boxer Capital owns less than approximately 0.1% of the company. In addition, the fund holds 2,100,000 shares of Cytokinetics Inc worth $147 billion, whose value grew 80.8% in the past six months. The third-largest holding is Revolution Medicines Inc worth $138 billion and the next is Tyra Biosciences Inc worth $106 billion, with 6,448,359 shares owned.

Currently, Boxer Capital's portfolio is worth at least $1.9 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Boxer Capital

The Boxer Capital office and employees reside in San Diego, California. According to the last 13-F report filed with the SEC, Aaron Davis serves as the Chief Executive Officer at Boxer Capital.

Recent trades

In the most recent 13F filing, Boxer Capital revealed that it had opened a new position in Sarepta Therapeutics Inc and bought 650,000 shares worth $84.1 billion. This means they effectively own approximately 0.1% of the company. Sarepta Therapeutics Inc makes up 5.4% of the fund's Health Care sector allocation and has decreased its share price by 15.6% in the past year.

The investment fund also strengthened its position in Revolution Medicines Inc by buying 295,200 additional shares. This makes their stake in Revolution Medicines Inc total 4,279,464 shares worth $138 billion. Revolution Medicines Inc soared 40.8% in the past year.

On the other hand, there are companies that Boxer Capital is getting rid of from its portfolio. Boxer Capital closed its position in Prometheus Biosciences Inc on 15th May 2024. It sold the previously owned 1,897,500 shares for $209 billion. Aaron Davis also disclosed a decreased stake in Nuvalent Inc by approximately 0.1%. This leaves the value of the investment at $84.1 billion and 1,120,192 shares.

One of the largest hedge funds

The two most similar investment funds to Boxer Capital are Swan Global Investments and Fullerton Fund Management Co. They manage $2.03 trillion and $2.03 trillion respectively.


Aaron Davis investment strategy

Boxer Capital’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Health Care — making up 77.3% of the total portfolio value. The fund focuses on investments in the United States as 59.6% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 4% of the total holdings value. On the other hand, small-cap stocks make up only 3.5% of the portfolio. The average market cap of the portfolio companies is close to $2.28 billion.

The complete list of Boxer Capital trades based on 13F SEC filings

These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Prometheus Biosciences Inc
Closed
1,897,500
$208,725,000,000
SpringWorks Therapeutics, Inc.
No change
3,421,541
$168,408,248,000 8.32%
Cytokinetics Inc
No change
2,100,000
$147,231,000,000 7.27%
Revolution Medicines Inc
7.41%
4,279,464
$137,927,125,000 6.81%
Tyra Biosciences Inc
No change
6,448,359
$105,753,088,000 5.22%
Apellis Pharmaceuticals Inc
9.52%
1,726,000
$101,454,280,000 5.01%
IDEAYA Biosciences, Inc.
No change
2,202,812
$96,659,391,000 4.77%
Mirati Therapeutics Inc
Closed
2,000,000
$90,620,000,000
Merus N.V
No change
1,900,000
$85,557,000,000 4.23%
Sarepta Therapeutics Inc
Opened
650,000
$84,149,000,000 4.16%
Nuvalent Inc
7.44%
1,120,192
$84,115,217,000 4.15%
BeiGene Ltd
No change
500,000
$78,195,000,000 3.86%
Tango Therapeutics Inc
15.09%
8,198,642
$65,097,217,000 3.22%
Nkarta, Inc.
Opened
5,607,350
$60,615,454,000 2.99%
Fate Therapeutics Inc
557.27%
8,215,910
$60,304,779,000 2.98%
Reata Pharmaceuticals Inc
Closed
1,230,004
$46,727,852,000
Avidity Biosciences, Inc.
54.05%
1,727,388
$44,082,942,000 2.18%
Akero Therapeutics Inc
101.65%
1,676,733
$42,354,276,000 2.09%
Sage Therapeutics Inc
Closed
1,094,000
$41,725,160,000
Rocket Pharmaceuticals Inc
No change
1,466,051
$39,495,414,000 1.95%
Argenx Se
Opened
100,000
$39,372,000,000 1.94%
Centessa Pharmaceuticals Plc
Closed
1,251,137
$38,785,245,000
Legend Biotech Corp
Opened
600,000
$33,654,000,000 1.66%
Axsome Therapeutics Inc
No change
400,000
$31,920,000,000 1.58%
Arcus Biosciences Inc
11.87%
1,602,200
$30,249,536,000 1.49%
AnaptysBio Inc
No change
1,300,000
$29,276,000,000 1.45%
Amicus Therapeutics Inc
Closed
2,325,000
$28,388,250,000
Ventyx Biosciences Inc
Closed
850,000
$27,871,500,000
Pmv Pharmaceuticals Inc
Closed
3,163,795
$27,525,016,000
Immunovant Inc
Opened
825,000
$26,655,750,000 1.32%
Bellus Health Inc
Closed
3,200,000
$26,304,000,000
Xenon Pharmaceuticals Inc
No change
600,000
$25,830,000,000 1.28%
Arvinas Inc
305.74%
608,614
$25,123,586,000 1.24%
iTeos Therapeutics, Inc.
16.25%
1,804,058
$24,607,351,000 1.22%
Viking Therapeutics Inc
80.00%
300,000
$24,600,000,000 1.22%
Oric Pharmaceuticals, Inc.
64.38%
1,732,571
$23,822,851,000 1.18%
Kura Oncology Inc
Opened
1,000,000
$21,330,000,000 1.05%
Geron Corp.
25.93%
6,000,000
$19,800,000,000 0.98%
Day One Biopharmaceuticals I
No change
1,189,943
$19,657,858,000 0.97%
Third Harmonic Bio Inc
250.62%
2,000,000
$18,880,000,000 0.93%
KalVista Pharmaceuticals Inc
Opened
1,590,000
$18,857,400,000 0.93%
Exelixis Inc
Closed
1,150,000
$18,446,000,000
Point Biopharma Global Inc
Closed
2,500,000
$18,225,000,000
89bio Inc
Closed
1,400,000
$17,822,000,000
IVERIC bio Inc
Closed
825,000
$17,663,250,000
Allogene Therapeutics Inc
Opened
3,850,000
$17,209,500,000 0.85%
Rain Oncology Inc
Closed
2,147,212
$17,177,696,000
Structure Therapeutics Inc
Opened
400,000
$17,144,000,000 0.85%
Prothena Corp Plc
130.00%
690,000
$17,091,300,000 0.84%
Sana Biotechnology Inc
Opened
1,545,000
$15,450,000,000 0.76%
Relay Therapeutics, Inc.
16.14%
1,819,132
$15,098,796,000 0.75%
Poseida Therapeutics, Inc.
Opened
4,475,000
$14,275,250,000 0.71%
Nurix Therapeutics, Inc.
Closed
1,224,892
$13,449,314,000
Engene Holdings Inc
Opened
727,900
$12,337,905,000 0.61%
Prelude Therapeutics Inc
Opened
2,568,287
$12,173,680,000 0.60%
Enliven Therapeutics Inc
Opened
671,358
$11,809,187,000 0.58%
Ascendis Pharma A/S
Closed
95,000
$11,602,350,000
Cullinan Oncology, LLC
Closed
1,074,082
$11,331,565,000
Iovance Biotherapeutics Inc
50.17%
750,000
$11,115,000,000 0.55%
Jasper Therapeutics Inc
Opened
350,000
$10,276,000,000 0.51%
Boundless Bio Inc
Opened
711,329
$10,136,438,000 0.50%
Spyre Therapeutics Inc
Opened
250,000
$9,482,500,000 0.47%
Century Therapeutics Inc
Opened
1,750,000
$7,315,000,000 0.36%
Gossamer Bio, Inc.
Closed
3,336,928
$7,241,134,000
Zentalis Pharmaceuticals, Llc
Opened
450,000
$7,092,000,000 0.35%
Panacea Acquisition Corp Ii
Closed
500,000
$6,208,060,000
Cogent Biosciences, Inc.
Closed
525,000
$6,069,000,000
Cabaletta Bio Inc
Closed
540,000
$4,995,000,000
2seventy Bio Inc
Closed
459,836
$4,308,663,000
Amylyx Pharmaceuticals Inc
28.02%
1,500,000
$4,260,000,000 0.21%
Absci Corporation
Opened
700,000
$3,976,000,000 0.20%
Selecta Biosciences Inc
Closed
3,284,072
$3,711,001,000
Kinnate Biopharma Inc.
Closed
510,000
$3,111,000,000
Atara Biotherapeutics Inc
Opened
4,150,000
$2,880,100,000 0.14%
Black Diamond Therapeutics I
74.89%
506,000
$2,565,420,000 0.13%
Direxion Shs Etf Tr
Opened
350,000
$2,551,500,000 0.13%
Ngm Biopharmaceuticals Inc
Closed
500,000
$2,510,000,000
Health Sciences Acq Corp 2
Closed
250,000
$2,495,000,000
Eqrx Inc
Closed
1,000,000
$2,460,000,000
BioAtla, Inc.
No change
686,347
$2,361,034,000 0.12%
Theseus Pharmaceuticals Inc
Closed
415,000
$2,066,700,000
Veru Inc
Closed
347,300
$1,833,744,000
Atreca Inc
Closed
2,202,333
$1,763,188,000
Mereo BioPharma Group plc
Closed
2,250,000
$1,687,500,000
Orchestra Biomed Hldgs Inc
Opened
238,193
$1,255,277,000 0.06%
Alaunos Therapeutics Inc
Closed
1,500,000
$973,650,000
Protara Therapeutics Inc
No change
209,227
$839,000,000 0.04%
MEI Pharma Inc
Closed
2,913,091
$709,629,000
Milestone Pharmaceuticals In
55.78%
309,007
$553,123,000 0.03%
Dbv Technologies S A
65.52%
500,000
$374,550,000 0.02%
Disc Medicine Inc
Closed
130,000
$175,500,000
Bellicum Pharmaceuticals Inc
Closed
56,950
$41,004,000
No transactions found
Showing first 500 out of 92 holdings